Wednesday, 05 August 2020


Can-Fite APIs to be manufactured by China CRO

24 January 2013 | News | By BioSpectrum Bureau

Chemspec will manufacture Can-Fite's active pharmaceuticals ingredients (API)

Chemspec will manufacture Can-Fite's active pharmaceuticals ingredients (API)

Singapore: Israel-based Can-Fite BioPharma announced that the active pharmaceuticals ingredients (API) of CF101 and CF102 are up-scaled and manufactured by Chemspec, a leading Chinese CRO.

This will support the on-going advanced stage clinical trials conducted by the company with a more efficient and less costly procedure. It will also enable the company to supply API to its current and future strategic partners.


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account




Podcast

 

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls